Abstract. Trisomy 16q is a rare disorder with severe abnormalities, which always leads to early postnatal mortality. It usually results from a parental translocation, exhibiting 16q duplication associated with another chromosomal deletion. The present study reports on the clinical presentation and molecular cytogenetic results of a small-for-gestational-age infant, consisting of partial trisomy 16q21→qter and monosomy 2p25.3→pter. The proband presented with moderately low birthweight, small anterior fontanelles, prominent forehead, low hairline, telecanthus, flat nasal bridge, choanal atresia, clinodactyly of the fifth fingers, urogenital anomalies, congenital muscular torticollis and congenital laryngomalacia. The last two traits have not previously been reported in any trisomy 16q and monosomy 2p cases. The proband was trisomic for the 16q21→qter chromosomal region with the karyotype 46,XY,der(2)t(2;16)(p25;q21)pat. The chromosomal anomaly was the result of unbalanced segregation of a paternal balanced translocation, 46,XY,t(2;16)(p25;q21). In this case, molecular cytogenetic analysis had a critical role in delineating the proband's clinical phenotype. Although this patient had a 16q21→qter duplication and a 2p25.3→pter deletion, the latter may have had mild phenotypic effects when associated with trisomy 16q. The literature was also reviewed, focusing on cases with the same breakpoints, localizations and clinical features reported in recent years.
Introduction
Trisomy 16 is recognized as the most common type of trisomy in first-trimester spontaneous abortions, occurring in 1% of all clinically recognized pregnancies, while being rarer in the second and third trimesters (1) (2) (3) . Early lethality and incompattrimesters (1) (2) (3) . Early lethality and incompattrimesters (1) (2) (3) . Early lethality and incompatibility with life have been described as its major outcomes (1) . Trisomy 16 may be classified into three major types: Full trisomy, mosaics and partial trisomy of 16p or 16q. Since Schmickel (�� re�orted the fi rst case of ��� trisomy as identi-�� re�orted the fi rst case of ��� trisomy as identi-� re�orted the fi rst case of ��� trisomy as identire�orted the fi rst case of ��� trisomy as identire�orted the first case of ��� trisomy as identified using a chromosome banding techni�ue in �975, >30 cases of partial trisomy 16q have been described. The common clinical features of trisomy 16q include low birthweight, hypotonia, failure to thrive, psychomotor retardation, periorbital edema, high prominent forehead, microcephaly, low-set ears, flat nasal bridge, small and down-slanting �al�ebral fissures, micrognathia, hypertelorism, long philtrum and posterior cleft palate (3) . In the literature, few cases of 16q trisomy among liveborn infants have been reported. The unbalanced segregation of a parental balanced translocation frequently leads to partial trisomy 16, which is common in newborns and is associated with a wide range of clinical congenital abnormalities (5) .
Pure terminal deletions of 2p are rare in a clinical context. To date, ~30 such patients have been reported, who share the following common clinical features: Early-onset obesity/overweight associated with intellectual disabilities and behavioral difficulties (6) (7) (8) .
The present case study reports on a male newborn with multi-organ malformations exhibiting partial trisomy 16q21→qter and monosomy 2p25.3→pter. The proband exhibited the clinical manifestations of congenital muscular torticollis and congenital laryngomalacia, which have not been reported previously in either trisomy 16q or monosomy 2p. The clinical features of cases reported in the published literature were also described.
Case report
The proband was admitted to the neonatal department at The First Hospital of Jilin University (Changchun, Jilin) due to wet lung and small stature for his gestational age directly after A 32-year-old father and a 28-year-old mother, who had taken a tocolytic agent due to suspected risk of spontaneous abortion in the first trimester. Physical examination indicated that the proband had small anterior fontanelles, prominent forehead, low hairline, telecanthus, flat nasal bridge, choanal atresia, clinodactyly of the fifth fingers, small �enis and right cryptorchidism. Brain magnetic resonance imaging indicated no obvious brain abnormalities, but regular follow-up to dynamically observe the proband's neurological condition remained necessary. At the age of 2 days, abnormal findings from chest X-rays revealed pneumonia in the patient, with the ultrasonic cardiogram exhibiting patent ductus arteriosus. Given an intolerance for normal feeding of the patient, feeding was accomplished via a nasogastric tube. The patient also presented with poor psychomotor development. Considering that the subject failed a hearing screening test and was posifailed a hearing screening test and was posifailed a hearing screening test and was positive for cytomegalovirus pp65 antigen, ganciclovir therapy was performed. Subsequently, congenital muscular torticollis (at 19 days) and congenital laryngomalacia (at 24 days) were diagnosed. Finally, the proband developed stable vital signs and was discharged at the age of one month old. At 19 months after the proband's birth, a follow-up was performed, during which the presence of low-set ears, torticollis, hypotonia and an inability to walk were noted, and laryngeal wheezing during sleep was reported. The parents refused surgical treatments for the right cryptorchidism and laryngomalacia. The protocol of the present study was approved by the Ethics Committee of the First Hospital of Jilin University (Changchun, China) and written informed consent was obtained from the parents of the patient.
From the proband, 5 ml of peripheral blood was collected using a standard vacuum extraction blood-collecting system containing EDTA and heparin. Genomic DNA was isolated from whole blood using a QIAamp DNA Mini kit (Qiagen GmbH) in accordance with the manufacturer's protocol.
Chromosome microarray (CMA) was performed using Affymetrix CytoScan HD arrays, in accordance with the manufacturer's protocol. The procedure included genomic DNA extraction, digestion and ligation, PCR am�lification, PCR product �urification, �uantification and fragmentation, labeling, array hybridization, washing and scanning. The array was designed specifically for cytogenetic research, including ~1,950,000 copy number variation markers and 750,000 single-nucleotide polymorphism markers. Data were analyzed using Affymetrix Chromosome Analysis Suite v3.3 Software. Thresholds for genome-wide screening were set at ≥�00 kb for gains and ≥50 kb for losses. The detected copy number gains or losses were systematically To further identify the chromosomal anomalies, blood from the proband and the proband's parents was obtained for karyotyping after obtaining written informed consent, in accordance with conventional G-banding techniques. The ISCN 2013 nomenclature was used to describe the karyotype (10) . The proband's karyotype was 46,XY,der(2)t(2;16) (p25;q21)pat ( Fig. 2A) . The proband's father's karyotype was 46,XY,t(2;16)(p25;q21) ( Fig. 2B ) and the proband's mother's karyotype was 46,XX. Thus, the proband was trisomic for 16q21→qter due to unbalanced segregation of a paternally inherited balanced translocation. According to the follow-up, the patient remained alive and stable although he did not accept any further surgical treatments.
Discussion
The present study reports on a male infant with an unbalanced der(2)t(2;16)(p25;q21) chromosome resulting in a 2p25.3 deletion and 16q24.3 duplication, presenting with psychomotor retardation, small anterior fontanelles, prominent forehead, low hairline, telecanthus, flat nasal bridge, choanal atresia, finger and genital deformities and multiple other malformations.
Trisomy 16q21→qter is a rare chromosomal abnormality among the different types of trisomy 16q. Brisset et al (1) established a series of phenotype-genotype correlations for trisomy16q: High/prominent forehead, bitemporal narrowing, periorbital edema in the neonatal period; severe mental retaredema in the neonatal period; severe mental retaredema in the neonatal period; severe mental retarperiod; severe mental retarperiod; severe mental retardation; vertebral, genital and anal abnormalities associated with 16q24; distal joint contractures and camptodactyly with 16q23; cleft palate and renal anomalies with 16q22; beaked nose and gall bladder agenesis with 16q21; gut malrotation, and lung and liver anomalies with 16q13; and behavioral abnormalities with band 16q11-q13. Barber et al (11) concluded that duplications of proximal 16q were not associated with dysmorphic features, but were linked to speech delay, learning difficulties and behavioral �roblems. Laus et al (5) suggested that the involved region ranging from 16q11 to 16q22 was necessary for the characteristic phenotypes of trisomy 16q.
To establish phenotype-karyotype correlations for trisomy16q21→qter, the present study mainly compared the clinical features of the present case with those from the literature on partial trisomy 16q21→qter cases, as reviewed in Table I (3, (12) (13) (14) (15) (16) . The rates of the different clinical character-12-16). The rates of the different clinical character-). The rates of the different clinical characteristics are as follows: Psychomotor retardation (7/7), prominent forehead (6/7), hypotonia (6/7), low-set ears (6/7), respiratory distress (5/7), urogenital anomalies (5/7), flat nasal bridge (5/7), hypertelorism (4/7), weak sucking (4/7), clinodactyly of the fifth fingers (3/7� and small anterior fontanelles (2/7�. To the best of our knowledge, the �resent study was the first to report on congenital muscular torticollis and congenital laryngomalacia in a case of partial trisomy 16q21→qter. It is generally accepted that unbalanced segregation of a parental balanced translocation usually leads to chromosome partial trisomy and monosomy (16) . All cases of trisomy 16q21→qter in the reviewed literature were derived from a balanced translocation of parental origin, involving monosomy of the other chromosomes (2p25.3, 4q35.2, 9p24, 10q26.3, 15p13, 18p11.2 and 22p12) at the same time. In the present case, the proband's karyotype was 46,XY,der(2)t(2;16)(p25;q21)pat. The proband's mother had a normal karyotype, while the proband's father's karyotype was 46,XY,t(2;16)(p25;q21). The proband had thus clearly inherited a paternal unbalanced translocation between chromosomes 2 and ��. It is difficult to distinguish whether the clinical phenotypes are associated with trisomy 16q and monosomy 2p separately or are a consequence of the genome rearrangements. The major limitation of the present study is that published studies on partial trisomy 16q21→qter are limited, most of which attempt to establish the phenotypekaryotype correlation through the clinical manifestations. Part of the characteristics of the present case are different from those of cases reported in the previous literature, while partial phenotypes overlap with them, which enhances the current knowledge on the phenotype-karyotype correlation to a certain extent. Furthermore, as presented in Table I , poor postnatal survival has been reported, ranging from 18 days to 7 years. Although it is impossible to make an accurate prediction regarding the proband's survival, it is difficult to be optimistic about his longevity.
The selection of plausible candidate genes exhibiting a 'dose effect' may partly explain the clinically observed phenotypes. The 2p25.3 region involved in the present case contains the genes family with sequence similarity 110 member C (FAM110C), SH3 and SYLF domain containing 1(SH3YL1), acid phosphatase 1 (ACP1), FAM150B, trans-trans-transmembrane protein 18 (TMEM18) and syntrophin gamma 2(SNTG2). Doco-Fenzy et al (7� re�orted on five �atients with a 2p25 deletion presenting with early-onset obesity, hy�er�hagia, intellectual deficiency and behavioral difficulties. They speculated that the ACP1 and TMEM18 genes may be involved in early-onset obesity. Heterozygous loss of the SNTG2 gene has been reported to be associated with intellectual deficiency and behavioral difficulties. Zou et al (17) reported on a 7-year-old female patient with a de novo unbalanced der(2)t(2;16)(p25.3;q24.3) chromosome resulting in 2p25.3 deletion and 16q24.3 duplication. However, the distinct trisomy 16q causes various clinical manifestations, which explains that monosomy 2p may have mild effects (12) 1980 (13) 1989 (14) 1991 (3) 2010 (15) 2018 ( when associated with trisomy 16q. However, the haploinsufficiency of genes in the region of 2�25.3 has yet to be evaluated.
The genes in the region of 16q21-16q24.3 and the associated diseases are summarized in Table II . The region contains >250 genes including 61 morbidity-associated genes. The gene chromatin licensing and DNA replication factor 1(CDT1), located at 16q24.3, which is required for DNA replication at multiple stages of development and mitosis, is expressed only in the G1 and S phases (18) . The homozygous or compound heterozygous mutation of the gene CDT1 has been indicated to be associated with Meier-Gorlin syndrome 4. Patients with this syndrome usually have short stature, distinctive facial features, low-set/rotated ears, micrognathia, full lips, a narrow nose with a high nasal bridge, patellar aplasia/hypoplasia and abnormalities in sexual development. Small testes and cryptorchidism are also involved in this condition, along with difficulty in feeding and breathing �roblems (19) . Ankyrin repeat domain 11(ANKRD11), located in 16q24.3, is a member of a family of ankyrin repeat-containing cofactors that interacts with p160 nuclear receptor coactivators and inhibits ligand-dependent transcriptional activation (20) . Heterozygous mutation in the ANKRD11 gene has been reported to lead to KBG syndrome, characterized by short stature, global developmental delay, intellectual disability, distinctive craniofacial features, seizures, hypertelorism and skeletal abnormality (brachydactyly or clinodactyly) (21, 22) . However, the triplosensitivity of these genes caused by partial trisomy 16q has not been clearly described.
In conclusion, the present case study reports on a newborn suffering from multiple organ malformations, with 2p25.3 deletion and 16q21q24.3 duplication. Concomitant partial monosomy 2p and partial trisomy 16q is unusual in a clinical context. The present results not only underline the importance of trisomy 16q21→qter, but also uncover certain unprecedented clinical features, which expand on the current knowledge of the clinical phenotypes of trisomy 16q21→qter syndrome. The limited number of relevant previous studies put a restriction on the clear delineation of the phenotype-karyotype correlation of trisomy 16q21→qter. Considering the observed clinical manifestations, the SNTG2, CDT1 and ANKRD11 genes are plausible candidates contributing to the proband's phenotype. As more and more clinical and molecular cytogenetic evaluations of cases with partial trisomy 16q emerge, it is anticipated that more accurate information on genotype-phenotype correlations will be established. Taking all of the information obtained into consideration, pre-implantation genetic diaginto consideration, pre-implantation genetic diaginto consideration, pre-implantation genetic diagnosis and prenatal diagnosis would be the most suitable choice if the proband's parents intend to conceive again.
